(IBDW) iShares Trust - iShares - Ratings and Ratios
Corporate Bonds, 2031 Maturity, Investment Grade, USD Denominated
Dividends
| Dividend Yield | 4.78% |
| Yield on Cost 5y | 4.88% |
| Yield CAGR 5y | 54.88% |
| Payout Consistency | 100.0% |
| Payout Ratio | - |
| Risk via 10d forecast | |
|---|---|
| Volatility | 3.16% |
| Value at Risk 5%th | 5.24% |
| Relative Tail Risk | 0.58% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.61 |
| Alpha | 2.87 |
| CAGR/Max DD | 0.82 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.325 |
| Beta | 0.051 |
| Beta Downside | -0.002 |
| Drawdowns 3y | |
|---|---|
| Max DD | 7.75% |
| Mean DD | 1.60% |
| Median DD | 1.30% |
Description: IBDW iShares Trust - iShares November 13, 2025
The iShares iBonds Dec 2031 Term Corporate ETF (IBDW) tracks a dollar-denominated, taxable, investment-grade corporate bond index that only includes securities maturing between 1 Jan 2031 and 15 Dec 2031. The fund is required to hold at least 80 % of its assets in the index constituents and at least 90 % in the same fixed-income categories, making it a non-diversified, target-maturity vehicle.
As of the latest filing, IBDW carries an expense ratio of 0.15 % and reports a weighted-average duration of roughly 9.5 years, positioning it to be highly sensitive to changes in the 10-year Treasury yield. Its current 12-month yield sits near 4.8 %, reflecting the prevailing investment-grade corporate spread over Treasuries, which has been compressing as the Federal Reserve signals a slower pace of rate hikes. The fund’s assets under management (AUM) are modest-approximately $250 million-so trading liquidity can be thin relative to broader market ETFs.
For a deeper dive into how IBDW’s duration profile and credit-spread exposure compare to other target-maturity products, you might explore the analytical tools on ValueRay.
What is the price of IBDW shares?
Over the past week, the price has changed by -0.18%, over one month by +0.77%, over three months by +1.76% and over the past year by +7.09%.
Is IBDW a buy, sell or hold?
What are the forecasts/targets for the IBDW price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 23.2 | 9.5% |
IBDW Fundamental Data Overview November 24, 2025
Beta = 1.16
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 2.01b USD (2.01b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 2.01b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 2.01b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 6.20% (E(2.01b)/V(2.01b) * Re(6.20%) + (debt-free company))
Discount Rate = 6.20% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for IBDW ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle